---
document_datetime: 2026-01-05 17:30:00
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/telzir.html
document_name: telzir.html
version: success
processing_time: 0.26943
conversion_datetime: 2026-01-06 07:17:44.717541
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Telzir

[RSS](/en/individual-human-medicine.xml/65922)

##### Withdrawn

This medicine's authorisation has been withdrawn

fosamprenavir Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Telzir](#news-on)
- [Topics](#topics)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 21 November 2025, the European Commission withdrew the marketing authorisation for Telzir (fosamprenavir) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, ViiV Healthcare B.V., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Telzir was granted marketing authorisation in the EU on 12 July 2004 for the treatment of HIV-1 infection. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2009.

Telzir : EPAR - Medicine overview

English (EN) (120.64 KB - PDF)

**First published:** 15/05/2009

**Last updated:** 05/01/2026

[View](/en/documents/overview/telzir-epar-medicine-overview_en.pdf)

[Other languages (22)](#file-language-dropdown-188)

български (BG) (148.53 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/bg/documents/overview/telzir-epar-medicine-overview_bg.pdf)

español (ES) (121.46 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/es/documents/overview/telzir-epar-medicine-overview_es.pdf)

čeština (CS) (144.76 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/cs/documents/overview/telzir-epar-medicine-overview_cs.pdf)

dansk (DA) (120.5 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/da/documents/overview/telzir-epar-medicine-overview_da.pdf)

Deutsch (DE) (124.34 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/de/documents/overview/telzir-epar-medicine-overview_de.pdf)

eesti keel (ET) (117 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/et/documents/overview/telzir-epar-medicine-overview_et.pdf)

ελληνικά (EL) (158.28 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/el/documents/overview/telzir-epar-medicine-overview_el.pdf)

français (FR) (122.63 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/fr/documents/overview/telzir-epar-medicine-overview_fr.pdf)

hrvatski (HR) (144.11 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/hr/documents/overview/telzir-epar-medicine-overview_hr.pdf)

italiano (IT) (119.78 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/it/documents/overview/telzir-epar-medicine-overview_it.pdf)

latviešu valoda (LV) (156.17 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/lv/documents/overview/telzir-epar-medicine-overview_lv.pdf)

lietuvių kalba (LT) (141.78 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/lt/documents/overview/telzir-epar-medicine-overview_lt.pdf)

magyar (HU) (143.38 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/hu/documents/overview/telzir-epar-medicine-overview_hu.pdf)

Malti (MT) (145.72 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/mt/documents/overview/telzir-epar-medicine-overview_mt.pdf)

Nederlands (NL) (120.19 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/nl/documents/overview/telzir-epar-medicine-overview_nl.pdf)

polski (PL) (145.66 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/pl/documents/overview/telzir-epar-medicine-overview_pl.pdf)

português (PT) (192.62 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/pt/documents/overview/telzir-epar-medicine-overview_pt.pdf)

română (RO) (142.58 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/ro/documents/overview/telzir-epar-medicine-overview_ro.pdf)

slovenčina (SK) (144.6 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/sk/documents/overview/telzir-epar-medicine-overview_sk.pdf)

slovenščina (SL) (140.99 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/sl/documents/overview/telzir-epar-medicine-overview_sl.pdf)

Suomi (FI) (118.92 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/fi/documents/overview/telzir-epar-medicine-overview_fi.pdf)

svenska (SV) (119.94 KB - PDF)

**First published:**

15/05/2009

**Last updated:**

05/01/2026

[View](/sv/documents/overview/telzir-epar-medicine-overview_sv.pdf)

## Product information

Telzir : EPAR - Product Information

English (EN) (852.95 KB - PDF)

**First published:** 16/12/2009

**Last updated:** 05/01/2026

[View](/en/documents/product-information/telzir-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-788)

български (BG) (1.04 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/bg/documents/product-information/telzir-epar-product-information_bg.pdf)

español (ES) (880.16 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/es/documents/product-information/telzir-epar-product-information_es.pdf)

čeština (CS) (906.46 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/cs/documents/product-information/telzir-epar-product-information_cs.pdf)

dansk (DA) (827.84 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/da/documents/product-information/telzir-epar-product-information_da.pdf)

Deutsch (DE) (850.06 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/de/documents/product-information/telzir-epar-product-information_de.pdf)

eesti keel (ET) (795.87 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/et/documents/product-information/telzir-epar-product-information_et.pdf)

ελληνικά (EL) (1.15 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/el/documents/product-information/telzir-epar-product-information_el.pdf)

français (FR) (917.62 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/fr/documents/product-information/telzir-epar-product-information_fr.pdf)

hrvatski (HR) (919.11 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/hr/documents/product-information/telzir-epar-product-information_hr.pdf)

íslenska (IS) (977.64 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/is/documents/product-information/telzir-epar-product-information_is.pdf)

italiano (IT) (890.42 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/it/documents/product-information/telzir-epar-product-information_it.pdf)

latviešu valoda (LV) (1.02 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/lv/documents/product-information/telzir-epar-product-information_lv.pdf)

lietuvių kalba (LT) (898.93 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/lt/documents/product-information/telzir-epar-product-information_lt.pdf)

magyar (HU) (991.79 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/hu/documents/product-information/telzir-epar-product-information_hu.pdf)

Malti (MT) (1.23 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/mt/documents/product-information/telzir-epar-product-information_mt.pdf)

Nederlands (NL) (926.56 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/nl/documents/product-information/telzir-epar-product-information_nl.pdf)

norsk (NO) (836.06 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/no/documents/product-information/telzir-epar-product-information_no.pdf)

polski (PL) (1.14 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/pl/documents/product-information/telzir-epar-product-information_pl.pdf)

português (PT) (856 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/pt/documents/product-information/telzir-epar-product-information_pt.pdf)

română (RO) (1.02 MB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/ro/documents/product-information/telzir-epar-product-information_ro.pdf)

slovenčina (SK) (975.93 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/sk/documents/product-information/telzir-epar-product-information_sk.pdf)

slovenščina (SL) (950.43 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/sl/documents/product-information/telzir-epar-product-information_sl.pdf)

Suomi (FI) (843.77 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/fi/documents/product-information/telzir-epar-product-information_fi.pdf)

svenska (SV) (821.55 KB - PDF)

**First published:**

16/12/2009

**Last updated:**

05/01/2026

[View](/sv/documents/product-information/telzir-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IG1531 19/08/2022

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Telzir : EPAR - All Authorised presentations

English (EN) (27.16 KB - PDF)

**First published:** 08/11/2007

**Last updated:** 05/01/2026

[View](/en/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-265)

български (BG) (97.23 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/bg/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_bg.pdf)

español (ES) (27.83 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/es/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_es.pdf)

čeština (CS) (95.69 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/cs/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (28.11 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/da/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (27.58 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/de/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (28 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/et/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (93.61 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/el/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_el.pdf)

français (FR) (27.69 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/fr/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (65.78 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/hr/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (64.29 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/is/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_is.pdf)

italiano (IT) (27.24 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/it/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (95.88 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/lv/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (94.2 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/lt/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (67.1 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/hu/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (649.23 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/mt/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (588.43 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/nl/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (621.68 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/no/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_no.pdf)

polski (PL) (673.81 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/pl/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_pl.pdf)

português (PT) (589.24 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/pt/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_pt.pdf)

română (RO) (652.3 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/ro/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (670.33 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/sk/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (669.14 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/sl/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (588.97 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/fi/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (588.99 KB - PDF)

**First published:**

08/11/2007

**Last updated:**

05/01/2026

[View](/sv/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Telzir Active substance fosamprenavir calcium International non-proprietary name (INN) or common name fosamprenavir Therapeutic area (MeSH) HIV Infections Anatomical therapeutic chemical (ATC) code J05AE07

### Pharmacotherapeutic group

Antivirals for systemic use

### Therapeutic indication

Telzir in combination with low-dose ritonavir is indicated for the treatment of human-immunodeficiency-virus-type-1-infected adults, adolescents and children of six years and above in combination with other antiretroviral medicinal products.

In moderately antiretroviral-experienced adults, Telzir in combination with low-dose ritonavir has not been shown to be as effective as lopinavir / ritonavir. No comparative studies have been undertaken in children or adolescents.

In heavily pretreated patients, the use of Telzir in combination with low-dose ritonavir has not been sufficiently studied.

In protease-inhibitor-experienced patients, the choice of Telzir should be based on individual viral resistance testing and treatment history.

## Authorisation details

EMA product number EMEA/H/C/000534 Marketing authorisation holder

ViiV Healthcare BV

Van Asch van Wijckstraat 55H

Marketing authorisation issued 12/07/2004 Withdrawal of marketing authorisation 21/11/2025 Revision 48

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Telzir : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (1.21 MB - PDF)

**First published:** 16/12/2009

**Last updated:** 05/01/2026

[View](/en/documents/procedural-steps-after/telzir-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

CHMP post-authorisation summary of positive opinion for Telzir

Adopted

Reference Number: EMA/156121/2016

English (EN) (710.69 KB - PDF)

**First published:** 26/02/2016

**Last updated:** 05/01/2026

[View](/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-telzir_en.pdf)

Telzir-H-C-534-P46-0075 : EPAR - Assessment Report

Adopted

Reference Number: EMA/642265/2014

English (EN) (1.37 MB - PDF)

**First published:** 23/10/2014

**Last updated:** 05/01/2026

[View](/en/documents/variation-report/telzir-h-c-534-p46-0075-epar-assessment-report_en.pdf)

Telzir-H-C-534-II-0074 : EPAR - Assessment Report - Variation

Adopted

Reference Number: EMA/339053/2014

English (EN) (1.59 MB - PDF)

**First published:** 10/06/2014

**Last updated:** 05/01/2026

[View](/en/documents/variation-report/telzir-h-c-534-ii-0074-epar-assessment-report-variation_en.pdf)

Telzir-H-C-534-P46-0060 : EPAR - Assessment Report

Adopted

Reference Number: EMA/131182/2013

English (EN) (1.07 MB - PDF)

**First published:** 09/04/2013

**Last updated:** 05/01/2026

[View](/en/documents/variation-report/telzir-h-c-534-p46-0060-epar-assessment-report_en.pdf)

Telzir-H-C-534-II-0058 : EPAR - Assessment Report - Variation

Adopted

English (EN) (731.43 KB - PDF)

**First published:** 29/06/2011

**Last updated:** 05/01/2026

[View](/en/documents/variation-report/telzir-h-c-534-ii-0058-epar-assessment-report-variation_en.pdf)

Telzir-H-C-534-II-0041 : EPAR - Assessment Report - Variation

Reference Number: EMEA/CHMP/182021/2009

English (EN) (1011.13 KB - PDF)

**First published:** 07/04/2009

**Last updated:** 05/01/2026

[View](/en/documents/variation-report/telzir-h-c-534-ii-0041-epar-assessment-report-variation_en.pdf)

CHMP post-authorisation summary of positive opinion for Telzir on 19 February 2009

Adopted

Reference Number: EMEA/109046/2009

English (EN) (609.33 KB - PDF)

**First published:** 19/02/2009

**Last updated:** 05/01/2026

[View](/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-telzir-19-february-2009_en.pdf)

Telzir-H-C-534-II-0018 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (201.39 KB - PDF)

**First published:** 27/09/2007

**Last updated:** 05/01/2026

[View](/en/documents/scientific-discussion-variation/telzir-h-c-534-ii-0018-epar-scientific-discussion-variation_en.pdf)

## Initial marketing authorisation documents

Telzir : EPAR - Scientific Discussion

English (EN) (1.18 MB - PDF)

**First published:** 06/12/2005

**Last updated:** 05/01/2026

[View](/en/documents/scientific-discussion/telzir-epar-scientific-discussion_en.pdf)

Telzir : EPAR - Procedural steps taken before authorisation

English (EN) (669.83 KB - PDF)

**First published:** 06/12/2005

**Last updated:** 05/01/2026

[View](/en/documents/procedural-steps/telzir-epar-procedural-steps-taken-authorisation_en.pdf)

#### News on Telzir

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2016](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-february-2016) 26/02/2016

[Updated advice on body fat changes and lactic acidosis with HIV medicines](/en/news/updated-advice-body-fat-changes-lactic-acidosis-hiv-medicines) 23/10/2015

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 October 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-19-22-october-2015) 23/10/2015

#### Topics

- [Medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A61)

**This page was last updated on** 05/01/2026

## Share this page

[Back to top](#main-content)